BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/30/2022 5:08:22 AM | Browse: 255 | Download: 512
 |
Received |
|
2021-04-21 11:22 |
|
Peer-Review Started |
|
2021-04-21 11:26 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-08-08 09:31 |
|
Revised |
|
2021-08-17 08:43 |
|
Second Decision |
|
2022-02-24 06:14 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-02-27 20:05 |
|
Articles in Press |
|
2022-02-27 20:05 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2022-02-21 20:31 |
|
Typeset the Manuscript |
|
2022-03-23 05:24 |
|
Publish the Manuscript Online |
|
2022-04-30 05:08 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Clinical and Translational Research |
| Article Title |
Solute carrier family 2 members 1 and 2 as prognostic biomarkers in hepatocellular carcinoma associated with immune infiltration
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Qing Peng, Li-Yuan Hao, Ying-Lin Guo, Zhi-Qin Zhang, Jing-Min Ji, Yu Xue, Yi-Wei Liu, Jun-Lan Lu, Cai-Ge Li and Xin-Li Shi |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81873112 |
| Natural Science Foundation of Hebei Province |
H2020423009 |
| Hundred Outstanding Innovative Talents Support Program of Universities in Hebei Province |
SLRC2019043 |
| Basic Scientific Research Project of Hebei Provincial Colleges and Universities |
JTZ2020005 |
| Scientific and Technological Capability Improvement Project of the Hebei University of Chinese Medicine |
KTZ2019002 |
|
| Corresponding Author |
Xin-Li Shi, PhD, Professor, Department of Pathobiology and Immunology, Hebei University of Chinese Medicine, No.3 Xing Yuan Lu, Shijiazhuang, Hebei , China, Shijiazhuang 050200, Hebei Province, China. sxlsunshine@sina.com |
| Key Words |
Hepatocellular carcinoma; Solute carrier family 2 member 1; Solute carrier family 2 member 2; Prognostic; Immune infiltration |
| Core Tip |
We performed an integrated bioinformatics analysis to assess the influence of solute carrier family 2 member 1 (SLC2A1) and solute carrier family 2 member 2 (SLC2A2) in hepatocellular carcinoma (HCC). This study revealed that SLC2A1 and SLC2A2 are independent therapeutic targets in HCC and that they are correlated with immune infiltration, in addition to being involved in the metabolic reprogramming in HCC. |
| Publish Date |
2022-04-30 05:08 |
| Citation |
Peng Q, Hao LY, Guo YL, Zhang ZQ, Ji JM, Xue Y, Liu YW, Lu JL, Li CG, Shi XL. Solute carrier family 2 members 1 and 2 as prognostic biomarkers in hepatocellular carcinoma associated with immune infiltration. World J Clin Cases 2022; 10(13): 3989-4019 |
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i13/3989.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i13.3989 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
